Showing results (2201-2210 of 3,408) with videos related to
Sort By:
Pageof 341
Neuromuscular Disorders : NMD|March 16, 2013
Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathyEllen Cottenie, Manoj P Menezes, Alexander M Rossor, et al.Neuromuscular Disorders : NMD|May 23, 2013
Muscular dystrophy with large mitochondria associated with mutations in the CHKB gene in three British patients: extending the clinical and pathological phenotypeRos Quinlivan, Satomi Mitsuahashi, Caroline Sewry, et al.Neuromuscular Disorders : NMD|March 12, 2013
Performance of individual items of the quantitative myasthenia gravis scoreT Carolina Barnett, Vera Bril, Aileen M DavisNeuromuscular Disorders : NMD|December 15, 2012
Prednisolone-sparing effect of cyclosporin A therapy for very elderly patients with myasthenia gravisSeika Nakamura, Satoshi Kaneko, Akiyo Shinde, et al.Neuromuscular Disorders : NMD|January 24, 2013
Clinical and molecular study of a new form of hereditary myotonia in Murrah water buffaloAlexandre S Borges, José D Barbosa, Luiz Antônio L Resende, et al.Neuromuscular Disorders : NMD|January 8, 2013
Pregnancy during enzyme replacement therapy for late-onset acid maltase deficiencyFabien Zagnoli, Amelie Leblanc, Christian BlanchardNeuromuscular Disorders : NMD|February 12, 2013
Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohortMichela Catteruccia, Fabiana Fattori, Valentina Codemo, et al.Neuromuscular Disorders : NMD|February 15, 2013
Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophyJeffrey M Statland, Michael P McDermott, Chad Heatwole, et al.Neuromuscular Disorders : NMD|March 5, 2013
Oculopharyngeal muscular dystrophy as a cause of progression of weakness in antibody positive myasthenia gravisBjörn Oskarsson, Steven P RingelNeuromuscular Disorders : NMD|June 18, 2013
Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroidsNathalie Goemans, Marleen van den Hauwe, Rosamund Wilson, et al.Pageof 341